Condition: HBV · HCV · HDV · Sponsor: Vanessa Stadlbauer-Koellner, MD
The HEAL-S study is a non-interventional study with retrospective data analysis. It consists of two parts. First a retrospective analysis based on nucleic acid testing (NAT) results will be performed. Two cohorts (HCV) and (HBV) will be established. Patients falling into one (or both) of the two cohorts will be invited to a prospective linkage-to-care study. In this part, patients are invited to the clinic, where the possibility of hepatitis treatment will be discussed.
This description comes directly from the study's public registry record.
Vanessa Stadlbauer, Univ. Prof. Dr. · 0043 316 385 · vanessa.stadlbauer@medunigraz.at
Lavra Celcer, MPharm · gestudien@medunigraz.at
Always discuss trial participation with your own doctor first.
| Department of Internal Medicine, Division of Gastroenterology and Hepatology | Graz, Styra, Austria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06834178